Redesign Health India Fund: A Game-Changing Bet on Healthcare AI Startups
Redesign Health, a US-based healthcare-focused venture capital firm, has expanded its commitment to India’s digital health sector by launching a dedicated investment fund. Through a partnership with Mumbai-based Sky Impact Capital, the venture builder plans to support founders at the idea and pre-seed stages while helping them develop solutions that can scale both within India and internationally. The Redesign Health India fund marks one of the most significant moves by a global venture builder into the Indian healthcare AI space — and the timing couldn’t be sharper.
India’s digital health market was estimated at USD 14.50 billion in 2024 and is projected to reach USD 106.97 billion by 2033, growing at a CAGR of 25.12% from 2025 to 2033.That’s a market too large — and too urgent — for serious investors to ignore. Redesign Health isn’t ignoring it.
What Is the Redesign Health India Fund All About?
Announced on June 26, 2026, Redesign Health, a global venture and applied technology firm, announced its deeper expansion into India, with plans to invest in and partner with a new generation of founders building healthcare artificial intelligence (AI) companies for India and global markets.
As part of this effort, Redesign Health has partnered with healthcare-focused, operationally-oriented investment firm Sky Impact Capital and is in the process of raising a dedicated investment vehicle to support early-stage healthcare AI companies in India, with a focus on pre-seed and ideation-stage founders. Think of it less as a traditional fund and more as a company-creation engine — the kind that turns raw ideas into fundable, scalable businesses.
Although the fund’s target corpus has not been disclosed, the firm plans to back five to six startups every year, focusing on entrepreneurs who are still refining ideas or preparing to launch their companies. That’s a deliberately selective pace — quality over quantity, with deep operational support baked into every bet.
The geographic scope of the operation is already taking shape. Redesign Health has already established a 12-member team across Bengaluru and Mumbai to work alongside its global network.That’s boots on the ground, not just a press release.
Meet the Partners: Redesign Health and Sky Impact Capital
A Proven US Venture Builder Enters India
Redesign Health was founded in 2018 by CEO Brett Shaheen, first an investor at Goldman Sachs, then a private equity investor at Carlyle and hedge fund Lone Pine Capital. That pedigree explains why the firm doesn’t just write cheques — it co-builds companies from the ground up.
Redesign Health has launched more than 60 companies touching the lives of more than 15 million patients, and it’s raised more than $1.5 billion from institutional, sovereign and strategic investors. Among those companies are AI-powered platforms for older adults, surgical referral optimization tools, and chronic pain management businesses. The venture firm banked $175 million in December 2024 to cultivate 20 additional companies that address healthy aging, expanding sites of service and interoperability.
Brett Shaheen is direct about what drew him to India. “India represents one of the most important opportunities in global healthcare and AI,” said Shaheen. “The combination of engineering talent, clinical need, and system complexity creates the conditions to build solutions that are both locally transformative and globally relevant. We see an opportunity to partner with founders at the earliest stages and help them build companies that define the future of healthcare both within the country and at a global scale.”
Aakash Sachdev and Sky Impact Capital: The Local Powerhouse
The Redesign Health Sky Impact partnership draws enormous credibility from its local anchor. Aakash Sachdev, the driving force behind Sky Impact Capital India fund, is not an outsider to this space. Sachdev serves as founder and managing partner of Sky Impact Capital and co-founder and GP of Redesign Health India. That dual role makes him the connective tissue between the two organizations.
“Since inception in 2018, Sky Impact Capital has impacted millions of lives, and through this partnership, we believe we can work with exceptional founders, leverage technology to expand access and improve outcomes, and build leading healthcare companies for India and from India for the world.” That “from India for the world” framing is intentional — this isn’t a fund designed to serve only domestic demand. It’s global by design.
Why India? The Case for Early-Stage Healthcare AI Here
India’s combination of scale, scarcity, and technological sophistication makes it uniquely suited to produce world-class healthcare AI. India is emerging as a critical center of innovation, particularly in healthcare, where the need for scalable, technology-enabled solutions is immediate. India’s healthcare system operates at a level of scale and diversity that few other markets can match, creating an environment where AI solutions can be developed, tested, and refined across a wide range of real-world conditions.
The numbers back that up. The AI in healthcare market in India was valued at USD 435.7 million in 2025, and is projected to exhibit a CAGR of 29.56% during 2026–2034, reaching a value of USD 4,773.7 million. That growth trajectory isn’t accidental — it’s being driven by a confluence of government policy, infrastructure investment, and a deep bench of technical talent.
The AI in healthcare market size in India is also being propelled by the expanding digital health ecosystem supported by government initiatives like Ayushman Bharat Digital Mission and increased investments in health tech startups. For founders building early-stage healthcare AI in India, the runway has never looked longer.
At the same time, India’s growing base of engineers, clinicians, and entrepreneurs is increasingly focused on building companies with global reach. This is the cohort the Redesign Health Sky Impact partnership is betting on.
What Will the Redesign Health India Fund Actually Back?
Sectors and Priorities
The firm sees opportunities in AI solutions that improve healthcare access in Tier II and Tier III cities, enable specialty care providers to expand, strengthen healthcare payment systems, support India’s medical tourism sector, and advance preventive healthcare. That’s a comprehensive mandate — not a narrow niche.
Preventive care is especially close to the firm’s heart. “We’re especially concerned about preventive care, not only because it’s a great business opportunity, but because it’s critical to improve quality of life for patients and keep costs down from a system level,” one of the firm’s executives noted.
The firm also sees opportunities for collaboration with India’s pharmaceutical industry, particularly in AI solutions that improve research, operational workflows, and commercial performance. However, it will continue to prioritize software-led healthcare businesses over capital-intensive areas such as molecular drug discovery and medical devices.
That focus on software-led models is smart. It means faster iteration cycles, lower burn rates, and greater potential for global replication — exactly what early-stage healthcare AI startups need.
A Network That Opens Doors
One of the most compelling aspects of the Redesign Health India fund isn’t the capital. It’s the connections. The firm plans to leverage its relationships with healthcare providers, insurers, diagnostics companies, pharmaceutical firms, and investors across the US and the Middle East to help founders secure pilot projects, strategic partnerships, and future funding.
For a pre-seed founder in Bengaluru, that kind of network access is genuinely rare. Getting a pilot with a US insurer or a Middle Eastern healthcare system can be the difference between a startup that scales and one that stalls. Redesign Health has done this before — it teamed up with Mayo Clinic to hatch Corvus, a startup that streamlines the surgical referral process, and launched two companies with UPMC Enterprises: Pip Care and Glimmer Health.
How This Fits Redesign Health’s Global Expansion Playbook
India isn’t an isolated experiment for Redesign Health. It’s the latest chapter in a deliberate global strategy. Early in 2025, the venture firm unveiled a partnership with Sanabil Investments, a wholly owned company by the Public Investment Fund, to open the Sanabil Venture Studio by Redesign Health in Saudi Arabia. The partnership aims to jointly develop and launch at least 20 healthcare companies in the kingdom.
Shortly after, Redesign Health launched its Global Ventures Headquarters in Bengaluru, India, aiming for it to serve as a central hub for its international operations. The India presence was already taking root before this latest fund announcement — which means the Redesign Health Sky Impact partnership has a running start.
Beyond company creation, Redesign Health’s expansion is also focused on contributing to the evolution of India’s healthcare system itself. AI-enabled solutions developed in India have the potential to expand access to care across underserved populations, improve early detection and disease management, increase system efficiency in high-demand environments, and create new models for delivering care at scale.
This is venture capital with a systems-change mindset. That’s rarer than it sounds.
What Founders Should Know About the Early-Stage Healthcare AI India Opportunity
If you’re building in the early-stage healthcare AI India space right now, here’s what this partnership signals:
- Timing matters. Over the past several months, the team has spoken with more than a hundred healthcare and AI founders across India— meaning the pipeline is being built actively, not passively.
- Stage preference is clear. The Redesign Health India fund explicitly targets ideation and pre-seed founders. You don’t need a product — you need a compelling problem and a credible team.
- Software is king. Drug discovery and hardware plays won’t get traction here. Software-led, scalable, AI-driven models are the sweet spot.
- Global ambition is expected. Solutions built for India must also have the potential to travel. The fund isn’t interested in locally trapped ideas.
Redesign plans to work closely with healthcare providers, partners, and policymakers to support the responsible development and deployment of these technologies. That last point — policymakers — matters in a market where regulatory relationships can make or break a startup’s trajectory.
What’s Next for the Redesign Health India Fund?
With a team of investors and operators already established in India, Redesign Health is accelerating its buildout, advancing development partnerships, and progressing a pipeline of early-stage investment opportunities. Further updates, including initial company launches and strategic partnerships, are expected in the coming months.
The broader context is equally energizing. According to Tracxn, 39+ new healthtech startups were founded in the first half of 2025, and India’s digital infrastructure continues to mature rapidly. The conditions for a healthcare AI renaissance are in place.
Redesign Health’s model — painstakingly co-building companies rather than passively deploying capital — has worked at scale in the US. Since 2018, the firm has supported founders in launching more than 60 companies that have touched the lives of over 15 million patients and generated over $1 billion of revenue. Applying that playbook to India’s healthcare AI founders, with Aakash Sachdev’s local intelligence and Sky Impact Capital’s operational depth, is a combination worth watching closely.
The Redesign Health India fund isn’t just a fund announcement. It’s a declaration that the next generation of globally relevant healthcare AI companies could be built right here — in Bengaluru, in Mumbai, and in the cities beyond.
Conclusion: A High-Conviction Bet on India’s Healthcare Future
The Redesign Health Sky Impact partnership is exactly the kind of long-term, operationally serious commitment that Indian healthcare AI startups need. Not just money — mentorship, networks, global reach, and the hard-won playbook of a firm that has built over 60 companies. If you’re a founder working on early-stage healthcare AI in India, this is the fund to track. If you’re an investor looking for signals about where serious global capital is flowing, this announcement is your answer.
India’s moment in global healthcare AI is here. The Redesign Health India fund is one of the clearest bets yet that it’s real.
FAQs
Q1: What is the Redesign Health India fund?
A1: The Redesign Health India fund is a dedicated investment vehicle being raised by Redesign Health in partnership with Sky Impact Capital to support early-stage healthcare AI companies in India. The fund targets founders at the ideation and pre-seed stages and plans to back five to six startups annually.
Q2: Who is Aakash Sachdev of Sky Impact Capital?
A2: Aakash Sachdev is the Founder and Managing Partner of Sky Impact Capital, a Mumbai-based healthcare-focused investment firm. He also serves as Co-Founder and General Partner of Redesign Health India as part of the new partnership. Sky Impact Capital has been operating since 2018 and has impacted millions of lives across the healthcare space.
Q3: What types of healthcare AI startups will the Redesign Health India fund back?
A3: The fund will prioritize software-led healthcare AI businesses, particularly those addressing healthcare access in Tier II and Tier III cities, specialty care expansion, healthcare payment systems, medical tourism, and preventive care. It will not focus on capital-intensive areas like molecular drug discovery or medical devices.
Q4: How much is the Redesign Health India fund raising?
A4: The specific target corpus for the dedicated India fund has not been publicly disclosed. However, the fund intends to deploy capital into five to six startups per year.
Q5: What stage of companies does the Redesign Health India fund target?
A5: The fund explicitly targets founders at the idea stage and pre-seed stage — founders who are still refining their concepts or preparing to formally launch their companies. This is much earlier than most traditional VC funds.
Q6: What is Redesign Health’s track record before entering India?
A6: Since its founding in 2018 in New York, Redesign Health has supported founders in launching more than 60 healthcare companies, touching the lives of over 15 million patients and generating more than $1 billion in revenue. The firm raised a $175 million fund in December 2024 — its largest to date — to fuel further company creation.
Q7: How will the Redesign Health Sky Impact partnership support Indian founders beyond funding?
A7: Beyond capital, the partnership plans to leverage Redesign Health’s relationships with healthcare providers, insurers, diagnostics companies, pharma firms, and investors across the US and the Middle East. This network access helps Indian founders secure pilot projects, strategic partnerships, and future rounds of funding, which are often the hardest challenges for early-stage startups to navigate.